VERGELLI, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 2.960
NA - Nord America 2.828
AS - Asia 269
AF - Africa 6
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.069
Nazione #
US - Stati Uniti d'America 2.823
PL - Polonia 1.867
IT - Italia 258
SE - Svezia 241
IE - Irlanda 240
HK - Hong Kong 131
GB - Regno Unito 84
UA - Ucraina 77
DE - Germania 70
CN - Cina 57
FI - Finlandia 47
VN - Vietnam 35
JO - Giordania 25
BE - Belgio 23
ES - Italia 13
RU - Federazione Russa 13
FR - Francia 12
TR - Turchia 12
NL - Olanda 7
BR - Brasile 5
CA - Canada 5
IN - India 4
SC - Seychelles 4
SG - Singapore 4
CH - Svizzera 3
RO - Romania 3
EG - Egitto 2
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EU - Europa 1
JP - Giappone 1
Totale 6.069
Città #
Warsaw 1.866
Fairfield 445
Chandler 289
Dublin 239
Seattle 218
Ashburn 216
Cambridge 178
Woodbridge 177
Houston 153
Ann Arbor 144
Wilmington 134
Jacksonville 128
Florence 99
Altamura 88
Lawrence 83
Hong Kong 81
Princeton 71
Buffalo 56
Boardman 38
Boston 37
Medford 37
Beijing 31
Dong Ket 27
San Diego 26
Brussels 22
London 18
New York 18
Shanghai 16
Barcelona 13
Hillsboro 12
Moscow 12
Norwalk 10
Izmir 9
Phoenix 9
Falls Church 7
Frankfurt Am Main 7
Milan 6
Fuzhou 5
Gavirate 5
Los Angeles 5
Teresópolis 5
Andover 4
Napoli 4
Philadelphia 4
Tappahannock 4
Toronto 4
Auburn Hills 3
Bern 3
Esslingen am Neckar 3
Menlo Park 3
Misano Adriatico 3
Pune 3
Scandicci 3
Verona 3
Zhengzhou 3
Amsterdam 2
Carol Stream 2
Castelliri 2
Crawley 2
Dearborn 2
Leawood 2
Paris 2
Prescot 2
Redwood City 2
Salerno 2
Southwark 2
Timisoara 2
Trumbull 2
Whitechapel 2
Antwerpen 1
Atlanta 1
Bologna 1
Cairo 1
Campi Bisenzio 1
Chicago 1
Chieti 1
Dallas 1
Ergolding 1
Foligno 1
Garden City 1
Guangzhou 1
Hanover 1
Helsinki 1
Hounslow 1
Istanbul 1
Lappeenranta 1
Laurel 1
Minsk 1
Montecatini Terme 1
Montréal 1
North Babylon 1
Pescara 1
Redmond 1
Reggio Emilia 1
Rome 1
San Jose 1
San Pietro In Casale 1
Secaucus 1
Serra 1
Shenzhen 1
Totale 5.146
Nome #
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 240
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 229
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. 208
Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists 206
Synthesis and evaluation as antitubercular agents of 5-arylethenyl and 5-(hetero)aryl-3-isoxazolecarboxylate 202
Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives 199
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 195
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 190
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 186
Isoxazolo-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors 177
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4-(3H)-ones fluoroderivatives as human A1 adenosine receptor ligands 169
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 167
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase 160
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. 137
Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors 125
Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors 124
Synthesis of five and six-membered N-phenylacetamido substituted heterocycles as formyl peptide receptor agonists 123
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 121
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 112
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 108
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold 108
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 103
Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. 102
Cinnoline derivatives as human neutrophil elastase inhibitors 99
New pyrazolo[1',5':1,6]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors 98
4-AMINO-3(2H)-PYRIDAZINONES BEARING ARYLPIPERAZINYLALKYL GROUPS AND RELATED COMPOUNDS: SYNTHESIS AND ANTINOCICEPTIVE ACTIVITY 95
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 94
4-Amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action 90
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action 90
ISOXAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS LEISHMANIA MEXICANA PDE INHIBITORS 87
SELECTIVE ACAT INHIBITORS AS PROMISING ANTIHYPERLIPIDEMIC, ANTIATHEROSCLEROTIC AND ANTI-ALZHEIMER DRUGS 86
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase 85
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 84
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 84
4-amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: synthesis, SARs, and preliminary studies on the mechanism of action 83
NOVEL 3-ARYLAMINO- AND 3-CYCLOALKYLAMINO-5,6-DIPHENYLPYRIDAZINES ACTIVE AS ACAT INHIBITORS 82
6-Methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. 76
AIRWAY RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF A PDE 4 INHIBITOR WITH LOW AFFINITY FOR THE HIGH-AFFINITY ROLIPRAM BINDING SITE 75
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. 72
PDE5 Inhibitors and their applications 68
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 68
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype 63
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study 63
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 61
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 61
4-amino-5-vinyl-3(2H)-pyridazinones and related compounds: synthesis and evaluation of antinociceptive activity 51
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 51
Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity agents as potential agents for treatment of erectile dysfunction 50
SYNTHESIS AND EVALUATION OF SOME PYRAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS PDE5 INHIBITORS POTENTIALLY USEFUL AS PERIPHERAL VASODILATOR 46
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists 46
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators 45
Preparation of pyridazin-3(2H)-ones and their use as PDE4 inhibitors 44
Synthesis and evaluation of novel pyrrolo[2,3-d] and thieno[2,3-d]pyridazinones as in vitro antiproliferative agents 44
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis 44
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors 43
preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 42
Preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 41
NEW SYNTHESIS OF DIFFERENTLY FUSED PYRIDAZINONQUINOLINES 40
Molecular manipulation of the 1,5,6,7-tetrahydro-4 H -indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors 40
Alpha-2-agonist as analgesic agents 33
Pyridazin-3(2H)-one derivatives as novel PDE IV inhibitors 25
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets 23
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis 19
GABAA receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assay 15
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 12
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype 12
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration 11
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 8
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 8
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity 1
Totale 6.249
Categoria #
all - tutte 16.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019448 0 0 0 0 0 0 0 0 0 100 191 157
2019/20201.352 131 130 42 105 162 147 126 170 116 86 108 29
2020/20211.088 91 89 34 117 59 123 70 82 126 178 46 73
2021/2022508 16 34 40 17 17 32 17 36 20 39 121 119
2022/20231.232 123 271 47 102 99 207 153 65 99 5 42 19
2023/2024366 12 48 81 22 22 54 12 96 8 11 0 0
Totale 6.249